Consultations
This page contains details of ongoing consultations where the opinion and input of BIA members is sought.
If you are commenting on any consultation as an individual or on behalf of another organisation such as RCPath and you belong to the BIA please do copy your form to BIA@Hartleytaylor.co.uk. Responders will receive a BIA Guideline Review Support Certificate which can be used to self-credit up to 10 CPD points for commenting on a consultation and we will incorporate your individual/other organisation response into the response of the BIA.
Recently published consultations are listed below
The following consultations and surveys are currently open:
- BSAC Consultation: Updated MRSA Treatment Guidelines
- Healthcare professional survey: pharma communications strategies Ongoing
NHS England Specialised Commissioning Immunology & Allergy CRG stakeholder update
In March 2019 NHS England published updated commissioning criteria on the use of therapeutic immunoglobulin (Ig) in immunology, haematology, neurology and some infectious diseases as a significant proportion of Ig is used in these specialities. The criteria focused on those indications of high usage previously categorised as red (conditions for which Ig treatment is considered the highest priority because of a risk to life without treatment) and blue (conditions for which there is a reasonable evidence base for the use of Ig but other treatment options are available).
This second phase of the updated commissioning criteria is a review of the use of Ig in the remaining red or blue indications for rheumatology, dermatology and infectious disease within the current Clinical Guidelines for Immunoglobulin Use (2nd edition update; July 2011) and is expected to be published in March 2020.
NHSE Commissioning Criteria for the use of Ig for stakeholder testing .pdf
Stakeholder Testing Response Form Ig guidelines.docx
The third phase will be based on a detailed evidence review of the use of Ig in disorders categorised as grey indications, where the evidence base is weak or absent, or the disease is rare. As with red and blue indications, only those grey indications which are supported by adequate evidence of Ig efficacy will be commissioned.
Whilst the third phase of the criteria review is underway NHS England will continue to commission use in grey indications in line with the current Clinical Guidelines for Immunoglobulin Use.
NHS England would now appreciate your views on the use of Ig for the red and blue conditions as set out in this document. This document is being shared for two weeks of stakeholder testing, so please return your feedback to Anna.Goodman@gstt.nhs.uk by Thursday 30th January, 2020.
BSAC Consultation: Updated MRSA Treatment Guidelines
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
This document is now available for public consultation and has been prepared by a Guideline Development Group, led by Drs Erwin Brown and Nicholas Brown (BSAC) and Anna Goodman (BIA), in line with the BSAC’s policy for Guideline production.
Your input will significantly enhance this document. Please circulate and encourage your network of contacts to respond to the consultation.
Please return your comments to chorner@bsac.org.uk by 5pm, Friday 7th February 2020.
Healthcare professional survey - pharma communications strategies
Do you want to influence how you communicate with Pharma?
This survey is around pharma’s relationship with doctors and what they feel is appropriate / optimal in terms of content / channel of communication. The idea is to raise awareness in the pharmaceutical industry of how doctors want to be communicated with. The results of the survey will be published in the pharmaceutical press (pharmaphorum) as well as circulated through industry contacts. This is an opportunity for doctors to have a say in the way that they communicate with the pharma industry and should hopefully help to stimulate meaningful debate at a time where the relationship is somewhat strained.
Recently Published Consultations
Previous Consultations
NICE guideline: Cellulitis and erysipelas: antimicrobial prescribing Published Sept 2019
NICE consultation on Indicators Consultation closed
NICE guideline: Lyme disease Consultation closed 12/03/2019
NICE guideline: Lyme disease. Published April 2018
NICE guideline: otitis media (acute): antimicrobial prescribing. Published March 2018
NICE guidance: Cystic Fibrosis - Diagnosis and management. Published October 2017
UK SMI V 28: investigation of cytomegalovirus infection Consultation closed 27/12/2018
NICE draft guideline: Surgical site infections: prevention and treatment (update) Consultation closed 18/12/2018
NICE guideline CG191 Pneumonia in adults: diagnosis and management. Consultation closed 26/09/18
NICE draft guideline on acute cough: antimicrobial prescribing. Consultation closed 17/09/18
NICE consultation on proposed changes to the technology appraisals programme - phase 2. Consultation closed 01/03/18
UK NSC consultation on chlamydia screening in pregnancy. Consultation closed 22/02/18
BHIVA Standards of Care for People Living with HIV 2018. Consultation closed 20/02/18
BHIVA guidelines for the management of HIV infection in pregnant women 2018. Consultation closed 19/02/18
BHIVA guidelines for the management of TB/HIV co-infection in adults. Consultation closed 09/02/18
NICE guideline on hip, knee and shoulder replacement. Consultation closed 05/02/18
UK SMI B 29: Investigation of specimens for screening for MRSA. Consultation closed 02/02/18
Use of organs from Hepatitis C viraemic donors in Hepatitis C negative recipients. Consultation closed 02/02/18
NICE QS on cystic fibrosis. Consultation closed 19 January 2018. Expected publication: 18 May 2018
UK NSC consultation: antenatal screening for:
syphilis
HIV
hepatitis B
Consultation closed 20/12/17. Review process due to be completed March/April 2018.
Topic engagement exercise: NICE emergency and acute medical care QS. Consultation closed 01/12/17. Click for BIA comments.
UK NSC consultation: guidance on the development, production and review of information to support screening. Consultation closed 16/11/17. We hope to publish responses and an updated version of the guidance within 12 weeks of the conclusion of the consultation.
NICE draft guideline on Lyme disease. Published April 2018 Click for BIA comments
NICE QS Consultation: Sepsis. Published September 2017. Click for BIA comments on Sepsis QS
NICE QS Consultation: HIV testing - encouraging uptake. Published September 2017.
NICE QS Consultation: Physical health of people in prison. Published September 2017.
UK NSC consultation: antenatal screening for human t-cell lymphotrophic virus (HTLV). Review completed Dec 2017
PHE UK guidelines for the management of contacts of invasive Group A Streptococcus infection in community settings. Consultation closed 02/10/17
British Society for Rheumatology draft guidelines: Biological DMARD safety guidelines in inflammatory arthritis. Consultation closed 04/09/17.
NICE guidance on emergency and acute medical care in over 16s: service delivery and organisation. Consultation closed 14/08/17. Expected publication date: 20/12/17. Click for BIA comments submitted
NICE guideline on sore throat (acute): antimicrobial prescribing. Consultation closed 14/08/17. Expected publication date tbc. Click for BIA comments submitted
Stakeholder consultation: High Consequence Infectious Diseases Interim Paediatric. Consultation closed 19/07/17.
NICE draft guideline: Flu vaccination - increasing uptake. Expected publication date: 10/01/2018.
Click for BIA comments on this consultation
NICE Surveillance Reports - Healthcare associated infections: prevention and control in primary and community care. Survey closed 27/06/17.
UK SMI V 04 - Investigation of hepatitis B infection. Published June 2017
NICE draft guideline on sinusitis (acute): antimicrobial prescribing. Published October 2017
NICE draft guideline on cystic fibrosis: diagnosis and management. Published 25 October 2017. Click for BIA comments.
UK National Screening Committee consultation: screening for Group B Streptococcus in pregnancy. Review completed March 2017
NICE Quality Standard Topic Engagement Exercise: HIV testing: encouraging uptake. Published Sept 2017
NICE guideline on Managing Common Infections. Consultation closed 28/11/16. Expected publication date tbc.
NICE Quality Standard Consultation: Vaccine uptake in under 19's. Published March 2017
NICE Diagnostics Consultation Document: Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay). Published Jan 2017
NICE Consultation on Abbreviated Technology Appraisal (ATA) Process. Consultation closed 24/08/16. Comments are currently being reviewed and an updated version is due to be presented to the NICE board in November 2016.
NICE Tuberculosis Quality Standard Consultation. Published Jan 2017 Click for BIA Guidelines Secretary response.
Tailored review of Public Health England: Response from the BIA (June 2016)
NICE Guideline: Sickle cell disease: managing acute painful episodes in hospital - Surveillance consultation. Consultation closed 02/06/16. Anticipated review decision publication: August 2016
UK SMI V 37: Chlamydia trachomatis infection - testing by Nucleic Acid Amplification Tests (NAAT). Published May 2018, updated Jan 2017
NICE draft guideline consultation: Multimorbidity: clinical assessment and management. Guideline published September 2016.
NICE QS Diabetes in adults - published March 2011, updated Aug 2016. Click for BIA response.
NICE guideline Non-Hodgkin's lymphoma - published July 2016
NICE guideline Blood transfusion - published December 2016
NICE guideline Sepsis - published July 2016, updated Sept 2017
NICE QS Bronchiolitis in children - published June 2016
NICE guideline Cirrhosis in over 16s: assessment and management - published July 2016
UK Malaria Treatment Guidelines published May 2016